EuroPCR 2019: RDN in Patients with Hypertensive Heart Disease

Published: 30 May 2019

  • Views:

    Views Icon 9
  • Likes:

    Heart Icon 0

Dr Marshall Heradien (Stellenbosch University, Stellenbosch, ZA) discusses renal denervation in the prevention of atrial fibrillation and reduction in cardiovascular death in patients with hypertensive heart disease.

Filmed on site at EuroPCR 2019 by Radcliffe Cardiology


1. Why did you conduct this study?

2. What was the design and associated endpoints?

3. What were your findings?

4. How does this data compare to the ERADICATE-AF data recently presented at HRS 2019?

5. How should this data be interpreted and what is required to validate RDN as an AF prevention strategy?


Videography: Mike Knight

Interviewer: Liam O'Neill